Researchers Mapped Brain Networks for Alzheimer's Diagnosis
A new study successfully used PET and MRI scans to categorize cognitive impairment in 651 participants.
Updated on Oct. 13, 2026 in Alzheimer’s

Live Poll
Should medical diagnostics prioritize combining multiple imaging methods to improve accuracy in detecting brain diseases?
Researchers have characterized brain networks in healthy controls, mild cognitive impairment patients, and Alzheimer's disease patients using a combination of PET and MRI scans. By focusing on metabolic and structural networks, the study improved diagnostic accuracy across different cognitive health categories.
Why it matters
Identifying Alzheimer's disease in its early stages remains a significant medical challenge. This research provides a new method for analyzing brain network perturbations that could lead to more reliable diagnostic tools for clinicians.
The study utilized 651 total participants along with an external validation cohort of 45 individuals. Researchers specifically analyzed 32 AD-relevant regions of interest to map the brain network nodes.
The details
The team constructed population-level networks using probability density function-based similarity with Jensen-Shannon divergence. By deriving individualized perturbation networks relative to healthy control references, the researchers were able to better discriminate between disease categories.
Timeline
The research findings were published on October 13, 2026.
The Big Picture
This study advances the methodologies standardized by the Alzheimer's disease neuroimaging initiative protocol to improve clinical diagnostic precision. The findings represent a shift in how structural and metabolic brain data are integrated to identify early signs of cognitive decline.
This research provides a new framework that could eventually improve the accuracy of early-stage Alzheimer's diagnoses in clinical settings. Patients may see more precise diagnostic tools as these refined imaging analysis techniques move toward wider implementation.
The takeaway
This study demonstrates that fusing PET and MRI data can create highly accurate diagnostic signatures for cognitive impairment. Clinicians can look to these imaging markers as a potential path for earlier and more definitive patient assessments.
Further reading
For more information on diagnostic advancements, visit Alzheimer’s.
Source note: This article includes information reported by Nature.
Live Poll
Should medical diagnostics prioritize combining multiple imaging methods to improve accuracy in detecting brain diseases?






